Product Information

LISINOPRIL 30 MG TABLET is a generic product labeled by Exelan Pharmaceuticals Inc., priced at $0.0489 per EA under NDC 76282042101. Its NADAC has been published 640 times since Aug 20, 2014.

FDA first approved this application on Oct 29, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LISINOPRIL 30 MG TABLET

lisinopril
$0.0489per EA

Strength

30 mg/1

NDC

76282042101

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

LISINOPRIL

Approval Type

Generic (ANDA)

FDA Application

ANDA203508

FDA Approved

10/29/2013

TE Code

AB

On Market Since

3/22/2017

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors

Price Statistics

The NADAC for LISINOPRIL 30 MG TABLET has been published 640 times since Aug 20, 2014, and over the history we have for it it has declined 34.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0489 per EA
All-time high$0.0750 (Aug 12, 2015)
All-time low$0.0419 (Nov 20, 2024)
52-week high$0.0556
52-week low$0.0489
Median price$0.0599
Average price$0.0603
Largest weekly change+28.9% (Dec 23, 2015)
Weeks tracked640
Tracking sinceAug 20, 2014

Price History

1W

-3.4%

1M

-5.9%

3M

-9.6%

6M

-11.8%

1Y

-9.5%

3Y

-6.2%

5Y

-22.2%

All

-34.4%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LISINOPRIL 30 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for LISINOPRIL 30 MG TABLET, manufactured by Exelan Pharmaceuticals Inc., is $0.0489 per EA (NDC 76282042101), effective Nov 18, 2026.

How has the price of LISINOPRIL 30 MG TABLET changed over time?

Over the history we have for it, the NADAC for LISINOPRIL 30 MG TABLET has declined 34.4%. It has been tracked across 640 weekly CMS publications since Aug 20, 2014.

What are the highest and lowest recorded NADAC prices for LISINOPRIL 30 MG TABLET?

Since Aug 20, 2014, the NADAC for LISINOPRIL 30 MG TABLET has ranged from a low of $0.0419 (Nov 20, 2024) to a high of $0.0750 (Aug 12, 2015), with a median of $0.0599 per EA.

Are there cheaper alternatives to LISINOPRIL 30 MG TABLET?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LISINOPRIL 30 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures LISINOPRIL 30 MG TABLET?

LISINOPRIL 30 MG TABLET (NDC 76282042101) is labeled by Exelan Pharmaceuticals Inc., and CMS classifies it as a generic product.